Xinming Chi

470 total citations
19 papers, 351 citations indexed

About

Xinming Chi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinming Chi has authored 19 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinming Chi's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Ferroptosis and cancer prognosis (3 papers). Xinming Chi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Ferroptosis and cancer prognosis (3 papers). Xinming Chi collaborates with scholars based in China, United States and Ethiopia. Xinming Chi's co-authors include Shujuan Shao, Xuefeng Liu, Fang Peng, Yuxin Bai, Liyuan Zhang, Yang Song, Qimin Zhan, Baofeng Zhao, Xiaoyu Qi and Qing Miao and has published in prestigious journals such as PLoS ONE, Cancer Research and RSC Advances.

In The Last Decade

Xinming Chi

18 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinming Chi China 11 246 126 58 53 34 19 351
Hongjuan Cui China 11 305 1.2× 89 0.7× 59 1.0× 40 0.8× 31 0.9× 19 405
Yue Feng China 10 223 0.9× 73 0.6× 65 1.1× 55 1.0× 23 0.7× 12 367
Wenbin Zhang China 10 348 1.4× 138 1.1× 65 1.1× 35 0.7× 50 1.5× 15 481
Shumei Ma China 14 232 0.9× 122 1.0× 47 0.8× 52 1.0× 44 1.3× 40 432
Xinxin Xiong China 10 184 0.7× 94 0.7× 84 1.4× 50 0.9× 34 1.0× 17 417
Subrata K. Pore United States 14 349 1.4× 178 1.4× 54 0.9× 34 0.6× 33 1.0× 30 567
Hai-Yu Mo China 8 285 1.2× 187 1.5× 104 1.8× 53 1.0× 31 0.9× 10 454

Countries citing papers authored by Xinming Chi

Since Specialization
Citations

This map shows the geographic impact of Xinming Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinming Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinming Chi more than expected).

Fields of papers citing papers by Xinming Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinming Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinming Chi. The network helps show where Xinming Chi may publish in the future.

Co-authorship network of co-authors of Xinming Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Xinming Chi. A scholar is included among the top collaborators of Xinming Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinming Chi. Xinming Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chi, Xinming, et al.. (2025). Downregulation of lncRNA MNX1-AS1 promotes the ferroptosis and apoptosis of non-small cell lung cancer. International Journal of Medical Sciences. 22(5). 1052–1063.
2.
Wang, Jiaqi, Zhongyuan Tang, Zhengwu Sun, et al.. (2024). Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma. Cancer Cell International. 24(1). 17–17. 4 indexed citations
3.
Meng, Xiangpeng, et al.. (2024). Knockdown of NADK promotes LUAD ferroptosis via NADPH/FSP1 axis. Journal of Cancer Research and Clinical Oncology. 150(5). 228–228. 5 indexed citations
4.
Tang, Zhongyuan, Yue‐Biao Zhang, Jiaqi Wang, et al.. (2023). Protective effects of phosphocreatine on human vascular endothelial cells against hydrogen peroxide-induced apoptosis and in the hyperlipidemic rat model. Chemico-Biological Interactions. 383. 110683–110683. 3 indexed citations
5.
Peng, Fang, Xinming Chi, Xiangpeng Meng, et al.. (2023). GPX2 promotes EMT and metastasis in non‐small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis. FASEB BioAdvances. 5(6). 233–250. 24 indexed citations
6.
Wang, Yali, Weimin Zhang, Wenzhong Liu, et al.. (2021). Long Noncoding RNA VESTAR Regulates Lymphangiogenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma by Enhancing VEGFC mRNA Stability. Cancer Research. 81(12). 3187–3199. 43 indexed citations
7.
Wang, Yali, Yu Wang, Xiaoxu Liu, et al.. (2020). Long non‐coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma. Cell Proliferation. 53(4). e12750–e12750. 16 indexed citations
8.
Wang, Jin, et al.. (2020). <p>lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells</p>. Cancer Management and Research. Volume 12. 5527–5536. 17 indexed citations
9.
Zhao, Baofeng, Yang Song, Xinming Chi, et al.. (2020). Nogo-B receptor is required for stabilizing TGF-β type Ireceptor and promotes the TGF-β1-induced epithelial-to-mesenchymal transition of non-small cell lung cancer. Journal of Cancer. 12(3). 717–725. 5 indexed citations
10.
Li, Tongtong, Lele Xu, Wenzhong Liu, et al.. (2019). GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences. 65(4). 1032–1041. 10 indexed citations
11.
Bai, Yuxin, Xuefeng Liu, Xiaoyu Qi, et al.. (2019). PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway. EBioMedicine. 42. 311–325. 77 indexed citations
12.
Wang, Yutong, Yanfang Ding, Changyuan Wang, et al.. (2019). Dihydroartemisinin and doxorubicin co-loaded Soluplus®-TPGS mixed micelles: formulation characterization, cellular uptake, and pharmacodynamic studies. Pharmaceutical Development and Technology. 24(9). 1125–1132. 19 indexed citations
13.
Zhang, Zhiwei, Lu Zhang, Xinming Chi, et al.. (2018). Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin. Biomedicine & Pharmacotherapy. 109. 1541–1546. 33 indexed citations
14.
Zhao, Baofeng, Xiaoyu Qi, Fang Peng, et al.. (2018). Nogo-B receptor promotes epithelial–mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway. Cancer Letters. 418. 135–146. 39 indexed citations
15.
Li, Huimin, Zhikun Lin, Yuxin Bai, et al.. (2017). Sinomenine inhibits ovarian cancer cell growth and metastasis by mediating the Wnt/β-catenin pathway via targeting MCM2. RSC Advances. 7(79). 50017–50026. 6 indexed citations
16.
Long, Fei, Chengyong Dong, Keqiu Jiang, et al.. (2017). Melatonin enhances the anti-tumor effect of sorafenib via AKT/p27-mediated cell cycle arrest in hepatocarcinoma cell lines. RSC Advances. 7(34). 21342–21351. 20 indexed citations
17.
Sun, Bing, Yuxin Bai, Liyuan Zhang, et al.. (2016). Quantitative Proteomic Profiling the Molecular Signatures of Annexin A5 in Lung Squamous Carcinoma Cells. PLoS ONE. 11(9). e0163622–e0163622. 9 indexed citations
18.
Song, Yang, Bing Sun, Lihong Hao, et al.. (2016). Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma. Oncotarget. 7(36). 58470–58482. 12 indexed citations
19.
Zhou, Xin, Yang Song, Xinming Chi, et al.. (2014). PRP19 upregulation inhibits cell proliferation in lung adenocarcinomas by p21-mediated induction of cell cycle arrest. Biomedicine & Pharmacotherapy. 68(4). 463–470. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongjuan Cui Breakdown of academic impact, for papers by Yue Feng Breakdown of academic impact, for papers by Wenbin Zhang Breakdown of academic impact, for papers by Shumei Ma Breakdown of academic impact, for papers by Xinxin Xiong Breakdown of academic impact, for papers by Subrata K. Pore Breakdown of academic impact, for papers by Hai-Yu Mo
Rankless by CCL
2026